Pilar España

2.4k citations
61 papers · 1.9k indexed · h-index 23

Pilar España

61 papers receiving 1.9k citations

Peers

Pilar España
Comparison fields: 5 of 99
  • Cancer Research 588
  • Oncology 804
  • Pathology and Forensic Medicine 331
  • Molecular Biology 1.1k
  • Sensory Systems 68
Replace Luca Emanuele Pollina with:
Luca Emanuele Pollina Italy
Janet M. Cowan United States
Howard Mackey United States
Tetsuo Ito Japan
Simone Reu Germany
Nicolaus Friedrichs Germany
Ingo Schwaner Germany
Keiko Funa Sweden
Daichi Maeda Japan
J. M. Roberts United States
Pilar España relative to Luca Emanuele Pollina Italy Luca Emanuele Pollina's profile →
Citations per field
00.5×3.6×
Luca Emanuele Pollina · 1×
Citations per year

Countries citing papers authored by Pilar España

Since Specialization
Citations

This map shows the geographic impact of Pilar España's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pilar España with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pilar España more than expected).

Fields of papers citing papers by Pilar España

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pilar España. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pilar España. The network helps show where Pilar España may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Pilar España, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Pilar España Line = papers co-authored together Pilar España links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20141
2 200616
3 20054
4 200371
5 200310
6 200390
7 200144
8 20007
9 200080
10 200035
11 20009
12 1999109
13 19997
14 199961
15 19993
16 199932
17 199835
18 199411
19 19919
20
Phase II study of dianhydrogalactitol in malignant glioma.
197810

About Pilar España

Pilar España is a scholar working on Pathology and Forensic Medicine, Oncology and Cancer Research, having authored 61 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (13 papers), Lymphoma Diagnosis and Treatment (11 papers), Cancer-related Molecular Pathways (9 papers), Lung Cancer Treatments and Mutations (9 papers), Genetic factors in colorectal cancer (9 papers), BRCA gene mutations in cancer (8 papers), Epigenetics and DNA Methylation (7 papers) and DNA Repair Mechanisms (5 papers). The work is most often cited by research in Cancer Research (588 citations), Oncology (804 citations) and Pathology and Forensic Medicine (331 citations). Pilar España has collaborated with scholars based in Spain, United States and Germany. Frequent co-authors include Mariano Provencio, Félix Bonilla, J.M. Jurado, Gemma Domínguez, Javier Silva, José M. Silva, Blanca Cantos, F. Bonilla, Rufo Rodríguez and Antonio Sánchez. Their work appears in journals such as Genes Chromosomes and Cancer, The Journal of Pathology, Breast Cancer Research and Treatment, Cancer and Mutation research. Fundamental and molecular mechanisms of mutagenesis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026